Cell Growth & Differentiation, Vol 6, Issue 12 1579-1589, Copyright © 1995 by American Association of Cancer Research

ARTICLES

Overexpression of cyclin A in the mammary glands of transgenic mice results in the induction of nuclear abnormalities and increased apoptosis

DM Bortner and MP Rosenberg
Glaxo Wellcome, Inc., Research Triangle Park, North Carolina 27709, USA.

Aberrant expression of several cyclin genes has been demonstrated to be associated with many types of tumors. To determine the capacity of cyclin A to function as an oncogene in vivo, wild-type and mutant cyclin A proteins were specifically overexpressed in the mammary glands of transgenic mice using regulatory sequences from the ovine beta-lactoglobulin gene. Several lines of transgenic mice were generated that expressed human cyclin A or a nondegradable mutant version of human cyclin A, in which the amino-terminal 89 amino acids encompassing the cyclin destruction box were removed. The cyclin A transgene products were localized in the nuclei of mammary epithelial cells, and the transgenic mammary glands had an increase in cyclin A- and cdk2-associated H1 kinase activity. Many mammary epithelial cells in the transgenic glands exhibited nuclear abnormalities, including multinucleation and karyomegaly, which were suggestive of preneoplastic alterations. The abnormalities were more severe in mammary glands of the mutant cyclin A transgenics, which expressed a stabilized cyclin A protein. In situ analysis of mid-lactation mammary gland sections revealed increased numbers of apoptotic cells in the transgenic glands. Double transgenic animals were generated that expressed both the mutant human cyclin A and human cdk2 transgenes, and a more pronounced phenotype resulted. The bigenic mammary glands exhibited focal areas of hyperplasia, as well as a greater incidence of apoptosis than observed in the single transgenic glands, demonstrating in vivo cooperation between these genes in transformation and apoptotic signaling pathways.

This article has been cited by other articles:

				A. J. Russo, P. G. Magro, Z. Hu, W.-W. Li, R. Peters, J. Mandola, D. Banerjee, and J. R. Bertino E2F-1 Overexpression in U2OS Cells Increases Cyclin B1 Levels and cdc2 Kinase Activity and Sensitizes Cells to Antimitotic Agents. Cancer Res., July 15, 2006; 66(14): 7253 - 7260. [Abstract] [Full Text] [PDF]

				M. Sugaya, T. Watanabe, A. Yang, M. F. Starost, H. Kobayashi, A. M. Atkins, D. L. Borris, E. A. Hanan, D. Schimel, M. A. Bryant, et al. Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter Blood, March 15, 2005; 105(6): 2356 - 2363. [Abstract] [Full Text] [PDF]

				W. H. Shen, S. T. Jackson, S. R. Broussard, R. H. McCusker, K. Strle, G. G. Freund, R. W. Johnson, R. Dantzer, and K. W. Kelley IL-1{beta} Suppresses Prolonged Akt Activation and Expression of E2F-1 and Cyclin A in Breast Cancer Cells J. Immunol., June 15, 2004; 172(12): 7272 - 7281. [Abstract] [Full Text] [PDF]

				W. H. Shen, Y. Yin, S. R. Broussard, R. H. McCusker, G. G. Freund, R. Dantzer, and K. W. Kelley Tumor Necrosis Factor {alpha} Inhibits Cyclin A Expression and Retinoblastoma Hyperphosphorylation Triggered by Insulin-like Growth Factor-I Induction of New E2F-1 Synthesis J. Biol. Chem., February 27, 2004; 279(9): 7438 - 7446. [Abstract] [Full Text] [PDF]

				K. Balmanno, T. Millar, M. McMahon, and S. J. Cook {Delta}Raf-1:ER* Bypasses the Cyclic AMP Block of Extracellular Signal-Regulated Kinase 1 and 2 Activation but Not CDK2 Activation or Cell Cycle Reentry Mol. Cell. Biol., December 15, 2003; 23(24): 9303 - 9317. [Abstract] [Full Text] [PDF]

				D. Holzschu, L. A. Lapierre, and M. D. Lairmore Comparative Pathogenesis of Epsilonretroviruses J. Virol., December 1, 2003; 77(23): 12385 - 12391. [Full Text] [PDF]

				K. Jurchott, S. Bergmann, U. Stein, W. Walther, M. Janz, I. Manni, G. Piaggio, E. Fietze, M. Dietel, and H.-D. Royer YB-1 as a Cell Cycle-regulated Transcription Factor Facilitating Cyclin A and Cyclin B1 Gene Expression J. Biol. Chem., July 18, 2003; 278(30): 27988 - 27996. [Abstract] [Full Text] [PDF]

				F. Zhao, A. Vilardi, R. J. Neely, and J. K. Choi Promotion of Cell Cycle Progression by Basic Helix-Loop-Helix E2A Mol. Cell. Biol., September 15, 2001; 21(18): 6346 - 6357. [Abstract] [Full Text] [PDF]

				H.-M. Koo, M. J. McWilliams, W. G. Alvord, and G. F. Vande Woude Ras Oncogene-Induced Sensitization to 1-{{beta}}-D-Arabinofuranosylcytosine Cancer Res., December 1, 1999; 59(24): 6057 - 6062. [Abstract] [Full Text] [PDF]

				K. S. Choi, Y. W. Eom, Y. Kang, M. J. Ha, H. Rhee, J.-W. Yoon, and S.-J. Kim Cdc2 and Cdk2 Kinase Activated by Transforming Growth Factor-beta 1 Trigger Apoptosis through the Phosphorylation of Retinoblastoma Protein in FaO Hepatoma Cells J. Biol. Chem., November 5, 1999; 274(45): 31775 - 31783. [Abstract] [Full Text] [PDF]

				W. Li, J. Fan, D. Banerjee, and J. R. Bertino Overexpression of p21waf1 Decreases G2-M Arrest and Apoptosis Induced by Paclitaxel in Human Sarcoma Cells Lacking Both p53 and Functional Rb Protein Mol. Pharmacol., June 1, 1999; 55(6): 1088 - 1093. [Abstract] [Full Text]

				V. Reinke, D. M. Bortner, L. L. Amelse, K. Lundgren, M. P. Rosenberg, C. A. Finlay, and G. Lozano Overproduction of MDM2 in Vivo Disrupts S Phase Independent of E2F1 Cell Growth Differ., March 1, 1999; 10(3): 147 - 154. [Abstract] [Full Text]

				F. Tombolan, D. Renault, D. Brault, M. Guffroy, O. Perin-Roussel, F. Perin, and V. Thybaud Kinetics of induction of DNA adducts, cell proliferation and gene mutations in the liver of Muta(TM)Mice treated with 5,9-dimethyldibenzo[c,g]carbazole Carcinogenesis, January 1, 1999; 20(1): 125 - 132. [Abstract] [Full Text] [PDF]

				Y. Soini, P. Paakko, and V-P. Lehto Histopathological Evaluation of Apoptosis in Cancer Am. J. Pathol., October 1, 1998; 153(4): 1041 - 1053. [Full Text] [PDF]

				K Lundgren, R Montes de Oca Luna, Y B McNeill, E P Emerick, B Spencer, C R Barfield, G Lozano, M P Rosenberg, and C A Finlay Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53. Genes & Dev., March 15, 1997; 11(6): 714 - 725. [Abstract] [PDF]